242 related articles for article (PubMed ID: 27246404)
21. A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements.
Hsu SX; Siegel AB; Berk PD
Semin Liver Dis; 2010 Feb; 30(1):99-106. PubMed ID: 20175037
[TBL] [Abstract][Full Text] [Related]
22. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
23. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
24. On-treatment mortality predictors in chronic hepatitis B patients experiencing severe acute exacerbation: a prospective observational study.
Chen YC; Hsu CW; Chang MY; Yeh CT
BMC Res Notes; 2013 Sep; 6():349. PubMed ID: 24004574
[TBL] [Abstract][Full Text] [Related]
25. Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Raedle J; Roth WK; Oremek G; Caspary WF; Zeuzem S
Dig Dis Sci; 1995 Dec; 40(12):2587-94. PubMed ID: 8536517
[TBL] [Abstract][Full Text] [Related]
26. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma and multiple myeloma with elevated globulin: a case report and literature review.
Xu L; Yang W; Shu YF; Xu XF
J Int Med Res; 2020 May; 48(5):300060520920395. PubMed ID: 32363985
[TBL] [Abstract][Full Text] [Related]
28. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY
J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
[TBL] [Abstract][Full Text] [Related]
29. Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants.
Yang SC; Lee CM; Hu TH; Wang JH; Lu SN; Hung CH; Changchien CS; Chen CH
J Antimicrob Chemother; 2013 Sep; 68(9):2154-63. PubMed ID: 23620466
[TBL] [Abstract][Full Text] [Related]
30. Very high alpha-fetoprotein in a young man due to concomitant presentation of hepatocellular carcinoma and Sertoli cell testis tumor.
Ersoy O
World J Gastroenterol; 2005 Nov; 11(44):7051-3. PubMed ID: 16437617
[TBL] [Abstract][Full Text] [Related]
31. [Alpha-fetoprotein: diagnostic value in hepatic disorders].
Kreczko S; Lipska A; Wysocka J
Pol Merkur Lekarski; 2000 Jun; 8(48):420-3. PubMed ID: 10967924
[TBL] [Abstract][Full Text] [Related]
32. An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults.
Lee HW; Park JY; Ahn SH
Expert Rev Gastroenterol Hepatol; 2016; 10(2):177-86. PubMed ID: 26610256
[TBL] [Abstract][Full Text] [Related]
33. Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma.
Bae JS; Park SJ; Park KB; Paik SY; Ryu JK; Choi CK; Hwang TJ
Korean J Intern Med; 2005 Mar; 20(1):80-5. PubMed ID: 15906959
[TBL] [Abstract][Full Text] [Related]
34. Concanavalin A affinity of alpha-fetoprotein. Its use in differentiating tumors.
Govindarajan S; Fong TL; Ashcavai M
Am J Clin Pathol; 1987 Dec; 88(6):722-4. PubMed ID: 2446494
[TBL] [Abstract][Full Text] [Related]
35. alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.
Lok AS; Lai CL
Hepatology; 1989 Jan; 9(1):110-5. PubMed ID: 2461890
[TBL] [Abstract][Full Text] [Related]
36. HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability.
Kim GA; Lim YS; An J; Lee D; Shim JH; Kim KM; Lee HC; Chung YH; Lee YS; Suh DJ
Gut; 2014 Aug; 63(8):1325-32. PubMed ID: 24162593
[TBL] [Abstract][Full Text] [Related]
37. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma.
Abbasi A; Bhutto AR; Butt N; Munir SM
J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098
[TBL] [Abstract][Full Text] [Related]
38. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis.
Wong GL; Chan HL; Mak CW; Lee SK; Ip ZM; Lam AT; Iu HW; Leung JM; Lai JW; Lo AO; Chan HY; Wong VW
Hepatology; 2013 Nov; 58(5):1537-47. PubMed ID: 23389810
[TBL] [Abstract][Full Text] [Related]
39. [Clinical and etiologic features of hepatocarcinoma in Sicily].
Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G
Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015
[TBL] [Abstract][Full Text] [Related]
40. Economic analysis between entecavir and lamivudine for the treatment of chronic hepatitis B in Hong Kong.
Lee KK; Wu DB; Chow PY; Lee VW; Li H
J Gastroenterol Hepatol; 2012 Jul; 27(7):1167-74. PubMed ID: 22141402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
